- ISIN
- US68170A1088
- Sector
- Healthcare
- Industry
- Health Information Services
- IPO Date
- Jun 6, 2025
Highlights
- EPS (TTM)
- -$0.08
- Total Revenue (TTM)
- $205.25M
- Gross Profit (TTM)
- $138.54M
- EBITDA (TTM)
- -$3.65M
- Year Range
- $10.28 - $26.92
- Target Price
- $22.40
- ROA (TTM)
- -1.10%
- ROE (TTM)
- -1.42%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
OMDA Performance Chart
Omada Health, Inc (OMDA) is up 13.9% since the beginning of the year. At $18 per share, OMDA is trading 33.2% below its 52-week high of $27.
Loading charts...
Returns By Period
Omada Health, Inc (OMDA) has returned 13.94% so far this year and 18.29% over the past 12 months.
Omada Health, Inc
- 1D
- 1.93%
- 1M
- 8.90%
- YTD
- 13.94%
- 6M
- 16.07%
- 1Y
- 18.29%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
OMDA Monthly Returns History
Based on dividend-adjusted daily data since Jun 6, 2025, OMDA's average daily return is -0.01%, while the average monthly return is -0.46%.
Historically, 46% of months were positive and 54% were negative. The best month was Aug 2025 with a return of +35.2%, while the worst month was Nov 2025 at -23.8%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 4 months.
On a daily basis, OMDA closed higher 51% of trading days. The best single day was Aug 6, 2025 with a return of +12.2%, while the worst single day was Jun 10, 2025 at -19.5%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -5.26% | -17.86% | 2.36% | 15.99% | 23.25% | 0.06% | 13.94% | ||||||
| 2025 | -20.43% | -4.26% | 35.22% | -6.67% | 11.13% | -23.77% | -15.75% | -31.39% |
Benchmark Metrics
Omada Health, Inc has an annualized alpha of -26.07%, beta of 1.18, and R2 of 0.05 versus S&P 500 Index. Calculated based on daily prices since June 06, 2025.
- This stock participated in 316.75% of S&P 500 Index downside but only 27.77% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.05 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -26.07%
- Beta
- 1.18
- R²
- 0.05
- Upside Capture
- 27.77%
- Downside Capture
- 316.75%
Return for Risk
Risk / Return Rank
OMDA ranks 51 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Omada Health, Inc (OMDA) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| OMDA | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.71 | ||
| Sortino ratioReturn per unit of downside risk | -1.94 | ||
| Omega ratioGain probability vs. loss probability | 1.10 | 1.37 | -0.26 |
| Calmar ratioReturn relative to maximum drawdown | 0.31 | 2.78 | -2.47 |
| Martin ratioReturn relative to average drawdown | 0.53 | 12.44 | -11.91 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Omada Health, Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Omada Health, Inc was 59.15%, occurring on Feb 11, 2026. The portfolio has not yet recovered.
The current Omada Health, Inc drawdown is 32.86%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2026 bear market2026 | -59.15%Feb 2026 | 3mo 15d | — | 7mo 27dOct 2025 - now |
2025 selloff2025 | -35.43%Jun 2025 | 14d | 2mo 5d | 2mo 19dJun 2025 - Aug 2025 |
2025 correction2025 | -11.12%Sep 2025 | 2d | 1mo 4d | 1mo 6dSep 2025 - Oct 2025 |
2025 pullback2025 | -1.97%Oct 2025 | 1d | 6d | 7dOct 2025 - Oct 2025 |
2025 pullback2025 | -0.88%Sep 2025 | 0s | 2d | 2dSep 2025 - Sep 2025 |
Drawdown Indicators
| OMDA | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -59.15% | -56.78% | -2.37% |
Max Drawdown (1Y)Largest decline over 1 year | -59.15% | -9.10% | -50.05% |
Max Drawdown (3Y)Largest decline over 3 years | — | -18.90% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -32.86% | -1.80% | -31.06% |
Average DrawdownAverage peak-to-trough decline | -30.42% | -10.71% | -19.71% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 34.44% | 2.03% | +32.41% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Omada Health, Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Omada Health, Inc is priced in the market compared to other companies in the Health Information Services industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for OMDA relative to other companies in the Health Information Services industry. Currently, OMDA has a P/S ratio of 3.8. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with OMDA
Add Omada Health, Inc to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with OMDA